$21.4B
$780,000
0.05% of portfolio
1,784
Q3 2024
Added 7.21%
$2.88B
$801,000
0.05% of portfolio
10,024
Q3 2024
Reduced 2.09%
$310B
$929,000
0.05% of portfolio
4,707
Q3 2024
Reduced 0.42%
$125M
$815,000
0.05% of portfolio
95,594
Q3 2024
Added 14.67%
$441M
$764,000
0.05% of portfolio
1,140,626
Q3 2024
Added 15.43%
$1.73B
$803,000
0.05% of portfolio
47,919
Q3 2024
Reduced 36.46%
$0
$657,000
0.04% of portfolio
2,316
Q3 2024
Reduced 50.02%
$6.22B
$685,000
0.04% of portfolio
5,599
Q3 2024
Reduced 2.96%
$8.43B
$750,000
0.04% of portfolio
4,739
Q3 2024
Reduced 2.97%
$15.5B
$720,000
0.04% of portfolio
3,362
Q3 2024
Reduced 2.35%
$24.8B
$681,000
0.04% of portfolio
3,010
Q3 2024
Reduced 0.2%
$9B
$705,000
0.04% of portfolio
10,215
Q3 2024
Reduced 2.44%
$325M
$601,000
0.04% of portfolio
93,440
Q3 2024
Added 22.93%
$12.5B
$725,000
0.04% of portfolio
10,327
Q3 2024
Reduced 50.06%
$12.2B
$625,000
0.04% of portfolio
10,150
Q3 2024
Reduced 2.39%
$398B
$690,000
0.04% of portfolio
1
Q1 2018
Reduced 50.0%
$36.2B
$607,000
0.04% of portfolio
9,338
Q3 2024
Reduced 1.9%
$8.41B
$525,000
0.03% of portfolio
9,748
Q3 2024
Reduced 2.96%
$21.9B
$521,000
0.03% of portfolio
4,834
Q3 2024
Reduced 2.28%
$5.28B
$426,000
0.03% of portfolio
9,339
Q3 2024
Reduced 0.78%
$300B
$497,000
0.03% of portfolio
3,377
Q3 2024
Reduced 9.63%
$3.81T
$584,000
0.03% of portfolio
2,510
Q2 2024
Reduced 5.64%
$8B
$508,000
0.03% of portfolio
7,814
Q3 2024
Reduced 2.21%
$197B
$570,000
0.03% of portfolio
5,008
Q3 2024
Reduced 0.75%
$6.25B
$464,000
0.03% of portfolio
7,045
Q3 2024
Added 0.74%
$45.4B
$432,000
0.03% of portfolio
6,555
Q3 2024
Reduced 2.24%
$2.09B
$454,000
0.03% of portfolio
56,761
Q3 2024
Added 23.39%
$37.3B
$429,000
0.03% of portfolio
5,496
Q3 2024
Reduced 0.31%
$11.6B
$538,000
0.03% of portfolio
20,766
Q3 2024
Reduced 3.01%
$252B
$343,000
0.02% of portfolio
4,248
Q1 2024
Added 189.77%
$3.27B
$347,000
0.02% of portfolio
1,350
Q2 2024
Reduced 6.9%
$444B
$400,000
0.02% of portfolio
3,413
Q2 2024
Reduced 6.65%
$104B
$301,000
0.02% of portfolio
1,350
Q3 2021
New
$3.12T
$313,000
0.02% of portfolio
728
Q3 2024
Reduced 2.02%
$83B
$264,000
0.02% of portfolio
558
Q3 2024
Reduced 36.08%
$5.13B
$315,000
0.02% of portfolio
3,796
Q3 2024
Reduced 3.01%
$23.6B
$325,000
0.02% of portfolio
8,308
Q3 2024
Reduced 2.75%
$376B
$262,000
0.02% of portfolio
1,519
Q3 2024
Reduced 26.23%
$704B
$396,000
0.02% of portfolio
1,882
Q3 2024
Reduced 8.55%
$4.7B
$408,000
0.02% of portfolio
5,344
Q3 2024
Reduced 2.85%
$7.88B
$249,000
0.01% of portfolio
3,455
Q3 2024
Reduced 1.34%
$106B
$240,000
0.01% of portfolio
2,468
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 6.37%
-
$0
0.0% of portfolio
-
Q3 2022
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 3.25%
Kiniksa Pharmaceuticals Intl
-
$0
0.0% of portfolio
-
Q3 2024
Added 8.16%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 4.32%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 2.14%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 3.51%